TrialJournal of neuro-oncology2018

A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.

Narayan Adhikari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.